Synthesis of current topics in immunology and virology, plus whatever I find interesting.
Sunday, May 3, 2009
Passing on a link: Michael Palm Basic Science, Vaccines, and Prevention Project Blog
In the meantime, I wanted to pass along this link to Michael Palm's blog for the Treatment Action Group (http://www.treatmentactiongroup.org/). It's a great resource for everything HIV related, and is current on HIV research findings.
If you really want to understand the immune system, just look at a virus which directly disrupts it.
His blog can be found at http://tagbasicscienceproject.typepad.com/
Saturday, April 4, 2009
System.out.println("The answer is 42");
Introduction
Friday has become my favorite day. Not because it's the weekend, oh no. No, Fridays are my favorite because I'm such a geek that I'm excited when The Journals come out. And even if you don't regularly scan their table of contents, you'd be hard pressed to miss the headlines in the science sections from the general news media: The first steps to a robot scientist are here people!
(All on the same story, but from different sources)
http://www.nytimes.com/2009/04/07/science/07robot.html
http://news.bbc.co.uk/2/hi/science/nature/7979113.stm
http://sciencenow.sciencemag.org/cgi/content/full/2009/402/1
http://blog.wired.com/wiredscience/2009/04/robotscientist.html
The actual scientific paper in Science is called The Automation of Science by King et al. at Aberystwyth University. There is also a comment on it and a related paper in the same issue (though the news outlets do a good job as well.)
Essentially, this robot, termed Adam, is able to complete the scientific process. Whereas computers and automation today are capable of collecting vast amounts of data, they have so far been unable to process it. Human scientists usually need to look at the data and determine what's useful. However, King et al. designed a system that can not only interpret the data and form a hypothesis about it, but can also perform followup experiments to test this hypothesis. To do this, they designed and implemented several different programs, ranging from hardware interaction to data collection and data analysis.
Just a note on the hardware: Adam is pretty beautiful, consising of multiple fridges, incubators, and robot arms. And, it never gets tired. The experiments involved growth curves of various yeast strains, which Adam can do hundreds of times a day. Just thinking about a human doing that amount of pipetting gives me thumb arthritis.
What Did Adam Actually Do?
Being a machine, Adam is great at hundreds of simple tasks and measurements. After taking specific yeast strains from the freezer, Adam can inoculate them in media and measure the ODs at various time points to establish a growth curve.
In order to test Adam, the authors decided to look at orphan enzymes, or enzymes for which the corresponding gene(s) haven't been identified. These enzymes have been well characterized in terms of their biochemical actions, so Adam is able to screen for enzyme activity by recording growth curves in specific media. Adam was also able to take advantage of yeast knockout strains for which the gene was known. Thus, Adam is able to take yeast that lack a gene and see if it is still able to grow when tested in a variety of limiting medias supplemented with certain metabolites. From this data, Adam is able hypothesize about the unknown gene encoding the orphan enzyme and is able to run further tests to confirm this hypothesis.
But Wait, There's More! (Bioinformatics)
One of the software packages I didn't talk about was their relational database of proteins and genes known to be present in yeast. Although the authors aren't descriptive, this is probably something similar to the DAVID Bioinformatics database (http://david.abcc.ncifcrf.gov/), Gene Ontology(http://www.geneontology.org/), or Pathways Analysis(http://www.ingenuity.com/products/pathways_analysis.html%20to)-- to name a few. I think this is the most important part of Adam, its "memory". Without such databases, it would be hard to understand gene and protein interaction and formulate an educated hypothesis.
Conclusion
Mass data collection, expanding bioinformatics tools, increasingly sophisticated programming, and efficient hardware are converging at the biological sciences, extending capability and knowledge at an exponential pace. Adam is only the beginning.
(If you don't believe me, read Ray Kurzweils The Singularity is Near, which, though on a slightly different topic, is on the same general trend. Or read about Eve at the group’s website, below.)
The paper is:
King et al. The Automation of Science. Science, vol. 324, April 3 2009.
http://www.ncbi.nlm.nih.gov/pubmed/19342587
The group's website can be found at:
http://www.aber.ac.uk/compsci/Research/bio/robotsci/
There are videos of Adam in action and other interesting things on the site
Sunday, March 29, 2009
Passing on a link: The Virological Synapse
Virogical Synapses and HIV Transmission
A new article at MIT's Technology Review highlights a recent paper about the way HIV is transmitted between CD4 T cells. Using a GFP-expressing virus, the authors ( show direct cell-to-cell transmission of HIV via formation of what's known as the virological synapse. Check it out at http://www.technologyreview.com/blog/editors/23244/
Mini Introduction to the topic:
Viruses (as well as bacteria) can infect cells in a variety of ways. Normally, we think of the route of entry as being mediated by cell surface receptors. The virus attaches to the cell through this method and is taken into the cell, where it begins to replicate itself. Later, the cell bursts, spilling thousands of viral progeny into the host; alternatively, the virus can continually bud off from the plasma membrane. (The virus can either do this right away or form a latent infection, where viral DNA is present but little viral protein is made. In this method, the virus rides along with the cell until conditions are right to start producing viruses again.)
The key point here is that at some point in their lifetime, viruses are thought to go extracellular; viral particles have to spread out and infect cells. And when they're out in the open like that, the host immune system can see them better; more arms are available to fight the virus. For example, a virus can be neutralized by antibody or a lipid envelope can be degraded by complement (to name only a few things). If a virus wasn't exposed to this arm at all, the immune system is at a disadvantage.
Relatively recent work has proposed the existence of a virological synapse which effectively transmits virus between cells without progeny having to ever enter the extracellular space. Essentially, the virological synapse is an immune synapse (in this instance, without the priming stage). MHC II, as well as adhesion molecules, are upregulated upon T cell activation. The adhesion molecules attach to other T cells and MHC II interacts with TCR, collectively forming a tight seal between T cells. Usually, this is good for T cell priming, in addition to probably playing a pertinent role in cytotoxic T cell ability.
However, CD4 T cells are a main target for human immunodefiency virus (HIV). Instead of a protective immunological synapse forming, infected CD4 T cells interacting tightly with uninfected CD4 T cells can pass on the virus through the immunological/virological synapse. This might happen a variety of ways (i.e. trogocytosis, active infection, etc) but the thing to keep in mind is, again, that this exchange is thought to keep out antibody and other effector molecules. Incidentally, if the immunological/virological synapse is presenting cognate antigen, it will help to activate (or keep activated) the uninfected CD4 T cell, which provides an excellent environment for the virus to replicate in.
Not having read the paper (sorry to so uninformed, more pressing papers to read), I don't know whether the authors prove this beyond a doubt. (For example, notice how long it takes for the uninfected CD4 T cell to become infected. Usually an infection is quicker- maybe there was virus in the supernatant that was the cause of the late GFP explosion in that CD4 T cell.) But regardless, it certainly strengthens the argument for a virological synpase and is another avenue scientists have to explore if we are ever going to effectively combat this virus.
It’d also be interesting if they took a look at FAS/FASL on these cells. If they are going to interact that strongly, what happens when activation-induced cell death (AICD) starts to really get going? (…Or does HIV inhibit this, I just don’t know.)
The actual paper can be found at: